Cargando…

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation

Hepatic ischemia/reperfusion (I/R) injury is a major cause of morbidity and mortality after liver surgery. Therefore, it is important to identity reliable biomarkers to assist early diagnosis of hepatic I/R injury. This study aimed to investigate the potential of serum levels of fibroblast growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Dewei, Li, Huating, Wang, Yudong, Jia, Weiping, Zhou, Jian, Fan, Jia, Man, Kwan, Lo, Chungmau, Wong, Chiming, Wang, Yu, Lam, Karen S.L., Xu, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726235/ https://www.ncbi.nlm.nih.gov/pubmed/26806156 http://dx.doi.org/10.1038/srep19776

Ejemplares similares

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
por: Wu, Liang, et al.
Publicado: (2017)

Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3
por: Li, Huating, et al.
Publicado: (2012)

Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2015)

Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Li, Huating, et al.
Publicado: (2018)

Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
por: Long, Xiaoxue, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)

Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
por: Chen, Shuqin, et al.
Publicado: (2017)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

Activation of CCL21-GPR174/CCR7 on cardiac fibroblasts underlies myocardial ischemia/reperfusion injury
por: Meng, Xiao-Wen, et al.
Publicado: (2022)

High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects
por: Chen, Cheng, et al.
Publicado: (2011)

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
por: Yan, Hongmei, et al.
Publicado: (2011)

Mechanistic Insight and Clinical Implications of Ischemia/Reperfusion Injury Post Liver Transplantation
por: Liu, Jiang, et al.
Publicado: (2023)

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019)

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose
por: Zhang, Jing, et al.
Publicado: (2017)

Circulating Exosomes Mediate Neurodegeneration Following Hepatic Ischemia-reperfusion Through Inducing Microglial Pyroptosis in the Developing Hippocampus
por: Wang, Yidan, et al.
Publicado: (2023)

The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury
por: Huang, Jia, et al.
Publicado: (2021)

Ischemic Postconditioning Protects Against Intestinal Ischemia/Reperfusion Injury via the HIF-1α/miR-21 Axis
por: Jia, Zhongzhi, et al.
Publicado: (2017)

Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia/reperfusion-induced injury in H9c2 cardiomyocytes
por: Hu, Shuoqiang, et al.
Publicado: (2017)

Transcriptomic Landscape of Circulating Extracellular Vesicles in Heart Transplant Ischemia–Reperfusion
por: Joo, SeoJeong, et al.
Publicado: (2023)

Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion
por: Deng, Lian-Cheng, et al.
Publicado: (2020)

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
por: Tang, Ying, et al.
Publicado: (2019)

Comments and hypotheses on the mechanism of methane against ischemia/reperfusion injury
por: Li, He, et al.
Publicado: (2017)

High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: Involvement of Peroxisome Proliferator–Activated Receptor γ Signaling
por: So, Wing Yan, et al.
Publicado: (2013)

Protective Effects of PPARγ on Renal Ischemia-Reperfusion Injury by Regulating miR-21
por: Huang, Ruizhen, et al.
Publicado: (2022)

Effects of Lipoic Acid on Ischemia-Reperfusion Injury
por: Ding, Yueming, et al.
Publicado: (2021)

Protective effects of circulating microvesicles derived from myocardial ischemic rats on apoptosis of cardiomyocytes in myocardial ischemia/reperfusion injury
por: Wang, Yao, et al.
Publicado: (2017)

Effect of Parecoxib Sodium on Myocardial Ischemia-Reperfusion Injury Rats
por: Wu, Fangyong, et al.
Publicado: (2021)

The protective effects of fibroblast growth factor 10 against hepatic ischemia-reperfusion injury in mice
por: Li, Santie, et al.
Publicado: (2021)

The action of mimetic peptides on connexins protects fibroblasts from the negative effects of ischemia reperfusion
por: Glass, Beverley J., et al.
Publicado: (2015)

Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
por: Lin, Zhuofeng, et al.
Publicado: (2015)

Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury
por: Salameh, Aida, et al.
Publicado: (2015)

Protective effect of celastrol on myocardial ischemia–reperfusion injury
por: Li, Xiaoyan, et al.
Publicado: (2017)

The anti-inflammatory effects of curcumin on renal ischemia-reperfusion injury in rats
por: Zhang, Jiong, et al.
Publicado: (2018)

Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion
por: Wu, Sijia, et al.
Publicado: (2022)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

Protective effect of morin on myocardial ischemia-reperfusion injury in rats
por: Liu, Shuang, et al.
Publicado: (2018)

Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
por: Lee, Chi Ho, et al.
Publicado: (2017)

TRIM37 exacerbates hepatic ischemia/reperfusion injury by facilitating IKKγ translocation
por: Yang, Hang, et al.
Publicado: (2023)

New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation
por: Liu, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mrclhnqsuejpadc5j3rmpd7bjs